In this study, we have investigated the effects of CBP/p300 KAT inhibitor A-485 and BD inhibitor GNE-049 on histone acetylation and the expression of ER target genes MYC and CCND1 in ER+ BC cell lines. This evidence concerns the gene CCND1 and breast cancer.